Emmanuelle Bondon‐Guitton

1.9k total citations
44 papers, 834 citations indexed

About

Emmanuelle Bondon‐Guitton is a scholar working on Toxicology, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Emmanuelle Bondon‐Guitton has authored 44 papers receiving a total of 834 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Toxicology, 17 papers in Pharmacology and 15 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Emmanuelle Bondon‐Guitton's work include Pharmacovigilance and Adverse Drug Reactions (25 papers), Drug-Induced Adverse Reactions (16 papers) and Pharmacological Effects and Toxicity Studies (9 papers). Emmanuelle Bondon‐Guitton is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (25 papers), Drug-Induced Adverse Reactions (16 papers) and Pharmacological Effects and Toxicity Studies (9 papers). Emmanuelle Bondon‐Guitton collaborates with scholars based in France, Sweden and Germany. Emmanuelle Bondon‐Guitton's co-authors include Jean‐Louis Montastruc, Haleh Bagheri, François Montastruc, Geneviève Durrieu, Maryse Lapeyre‐Mestre, Olivier Rascol, Santiago Perez‐Lloret, Vanessa Rousseau, Christine Brefel and Leila Chebane and has published in prestigious journals such as Psychopharmacology, Journal Of Clinical Periodontology and Clinical Pharmacology & Therapeutics.

In The Last Decade

Emmanuelle Bondon‐Guitton

44 papers receiving 806 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emmanuelle Bondon‐Guitton France 17 178 148 126 122 105 44 834
Luis H. Martín Arias Spain 14 174 1.0× 171 1.2× 73 0.6× 111 0.9× 72 0.7× 59 965
C Aguirre Spain 18 99 0.6× 137 0.9× 48 0.4× 111 0.9× 81 0.8× 55 846
Faizan Mazhar Sweden 18 83 0.5× 84 0.6× 79 0.6× 105 0.9× 99 0.9× 64 964
M. D. Rawlins United Kingdom 18 252 1.4× 155 1.0× 87 0.7× 229 1.9× 110 1.0× 45 1.1k
David M Coulter New Zealand 17 130 0.7× 108 0.7× 77 0.6× 250 2.0× 34 0.3× 42 1.1k
Lynda V. Wilton United Kingdom 23 145 0.8× 232 1.6× 38 0.3× 161 1.3× 36 0.3× 48 1.2k
Silvana Romio Netherlands 14 77 0.4× 218 1.5× 59 0.5× 50 0.4× 45 0.4× 27 912
Julien Bezin France 18 122 0.7× 107 0.7× 29 0.2× 109 0.9× 186 1.8× 67 1.2k
G Lagier France 12 374 2.1× 269 1.8× 52 0.4× 161 1.3× 124 1.2× 57 1.0k
David F. Kisor United States 21 70 0.4× 156 1.1× 42 0.3× 247 2.0× 61 0.6× 71 1.3k

Countries citing papers authored by Emmanuelle Bondon‐Guitton

Since Specialization
Citations

This map shows the geographic impact of Emmanuelle Bondon‐Guitton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuelle Bondon‐Guitton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuelle Bondon‐Guitton more than expected).

Fields of papers citing papers by Emmanuelle Bondon‐Guitton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmanuelle Bondon‐Guitton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuelle Bondon‐Guitton. The network helps show where Emmanuelle Bondon‐Guitton may publish in the future.

Co-authorship network of co-authors of Emmanuelle Bondon‐Guitton

This figure shows the co-authorship network connecting the top 25 collaborators of Emmanuelle Bondon‐Guitton. A scholar is included among the top collaborators of Emmanuelle Bondon‐Guitton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmanuelle Bondon‐Guitton. Emmanuelle Bondon‐Guitton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bondon‐Guitton, Emmanuelle, et al.. (2019). Does spontaneous adverse drug reactions’ reporting differ between different reporters? A study in Toulouse Pharmacovigilance Centre. Therapies. 74(5). 521–525. 4 indexed citations
2.
Wadelius, Mia, Niclas Eriksson, Reinhold Kreutz, et al.. (2017). Sulfasalazine‐Induced Agranulocytosis Is Associated With the Human Leukocyte Antigen Locus. Clinical Pharmacology & Therapeutics. 103(5). 843–853. 14 indexed citations
3.
Chenaf, Chouki, Aurore Gouraud, Milou D. Drici, et al.. (2017). Duloxetine and gingival bleeding: a case-report and reviews of the French and World PharmacoVigilance Databases and literature. European Journal of Clinical Pharmacology. 73(9). 1197–1198. 1 indexed citations
4.
Hallberg, Pär, Niclas Eriksson, Luisa Ibáñez, et al.. (2016). Genetic variants associated with antithyroid drug-induced agranulocytosis: a genome-wide association study in a European population. The Lancet Diabetes & Endocrinology. 4(6). 507–516. 62 indexed citations
5.
Bondon‐Guitton, Emmanuelle, Fabien Despas, & Laurent Becquemont. (2016). The contribution of pharmacogenetics to pharmacovigilance. Therapies. 71(2). 223–228. 3 indexed citations
6.
Despas, Fabien, et al.. (2016). Peripheral arterial occlusive disease during ponatinib therapy after failure of imatinib: a case report. Journal of Clinical Pharmacy and Therapeutics. 41(3). 360–361. 7 indexed citations
7.
Durrieu, Geneviève, Vanessa Rousseau, Haleh Bagheri, et al.. (2016). Apport de la visite d’assistants de recherche clinique aux cabinets de médecins généralistes sur la notification des effets indésirables médicamenteux. Therapies. 72(3). 351–355. 9 indexed citations
8.
Bagheri, Haleh, Isabelle Lacroix, Emmanuelle Bondon‐Guitton, Christine Damase‐Michel, & Jean‐Louis Montastruc. (2016). Cyberpharmacovigilance: What is the usefulness of the social networks in pharmacovigilance?. Therapies. 71(2). 235–239. 11 indexed citations
9.
Bondon‐Guitton, Emmanuelle, Haleh Bagheri, Françoise Huguet, et al.. (2016). Cardiovascular risk profile of patients with peripheral arterial occlusive disease during nilotinib therapy. Targeted Oncology. 11(4). 549–552. 13 indexed citations
10.
Rousseau, Vanessa, Robert Bourrel, Maryse Lapeyre‐Mestre, et al.. (2016). Drug–drug interactions with imatinib. Medicine. 95(40). e5076–e5076. 16 indexed citations
11.
Laccourreye, O., A. Werner, J.P. Giroud, et al.. (2015). Apport, dangers et limites de l’éphédrine et de la pseudoéphédrine en tant que décongestionnant nasal. Annales françaises d Oto-rhino-laryngologie et de Pathologie Cervico-faciale. 132(1). 28–31. 1 indexed citations
12.
Bondon‐Guitton, Emmanuelle, et al.. (2013). Spontaneous reporting of serious cutaneous reactions with protein kinase inhibitors. European Journal of Clinical Pharmacology. 69(10). 1819–1826. 21 indexed citations
13.
Bondon‐Guitton, Emmanuelle, et al.. (2013). Inhaled corticosteroid-induced hair depigmentation in a child.. PubMed. 12(1). 119–20. 3 indexed citations
14.
Perez‐Lloret, Santiago, et al.. (2012). Drugs Associated With Restless Legs Syndrome. Journal of Clinical Psychopharmacology. 32(6). 824–827. 19 indexed citations
15.
Fuzier, Régis, Isabelle Serres, Emmanuelle Bondon‐Guitton, Maryse Lapeyre‐Mestre, & Jean‐Louis Montastruc. (2012). Adverse Drug Reactions to Gabapentin and Pregabalin. Drug Safety. 36(1). 55–62. 44 indexed citations
16.
Montastruc, François, Agnès Sommet, Geneviève Durrieu, et al.. (2012). Importance of cytochrome P450 (CYP450) in adverse drug reactions due to drug–drug interactions: a PharmacoVigilance study in France. European Journal of Clinical Pharmacology. 69(4). 885–888. 24 indexed citations
17.
Montastruc, François, Agnès Sommet, Emmanuelle Bondon‐Guitton, et al.. (2011). The importance of drug–drug interactions as a cause of adverse drug reactions: a pharmacovigilance study of serotoninergic reuptake inhibitors in France. European Journal of Clinical Pharmacology. 68(5). 767–775. 33 indexed citations
18.
Bondon‐Guitton, Emmanuelle, Grégoire Prévôt, A. Didier, & Jean‐Louis Montastruc. (2011). Pulmonary Arterial Hypertension and Benfluorex: 5 Case Reports. Therapies. 66(2). 135–138. 5 indexed citations
19.
Perez‐Lloret, Santiago, Emmanuelle Bondon‐Guitton, Olivier Rascol, & Jean‐Louis Montastruc. (2010). Adverse drug reactions to dopamine agonists: A comparative study in the french pharmacovigilance database. Movement Disorders. 25(12). 1876–1880. 23 indexed citations
20.
Bondon‐Guitton, Emmanuelle, et al.. (2009). Confusion, a Rather Serious Adverse Drug Reaction with Valproic Acid: A Review of the French Pharmacovigilance Database. Pharmacopsychiatry. 42(2). 61–65. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luis H. Martín Arias Breakdown of academic impact, for papers by C Aguirre Breakdown of academic impact, for papers by Faizan Mazhar Breakdown of academic impact, for papers by M. D. Rawlins Breakdown of academic impact, for papers by David M Coulter Breakdown of academic impact, for papers by Lynda V. Wilton Breakdown of academic impact, for papers by Silvana Romio Breakdown of academic impact, for papers by Julien Bezin Breakdown of academic impact, for papers by G Lagier Breakdown of academic impact, for papers by David F. Kisor
Rankless by CCL
2026